GORDON KEVIN K sold $321K of PGNY
GORDON KEVIN K sold 11,500 shares of Progyny, Inc. (PGNY) at $27.94 ($0.32M total) on 2026-09-10.
How this was made
The 30-second read
Why it matters
The disclosed sale reduces the director's ownership, which may be interpreted as reduced confidence, but the size is modest relative to market cap.
Market read
Insider sale news is relevant for short‑term traders monitoring PGNY.
What to watch
No accompanying corporate news; the director may be diversifying holdings.
Background
Form 4 filings disclose insider transactions; director sales are monitored for potential signals.
Ticker impact
Director Gordon Kevin K sold 11,500 shares for $321,358, reducing his stake to 6,792 shares.
Possible modest downside pressure in the next trading session.
Director sales are closely watched; a $321k sale by a director is material for a mid‑cap biotech, but the amount is not large enough to trigger a sharp move.
Market effects
May raise questions about insider sentiment in the fertility benefits sector.
Limited to U.S. biotech investors.
Low global impact.
Counterpoint
The sale could be a routine liquidity event, not a negative signal.
Key entities
- CompanyProgyny, Inc.
Provider of fertility benefits solutions, ticker PGNY.
- InsiderGordon Kevin K
Director of Progyny who sold shares.
